Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia

BACKGROUND: Acute lymphoblastic leukemia (ALL) is known as the most prevalent pediatric malignancy all around the world. Identification of specific biomarker is necessary for early diagnosis and effective therapy. It is believed that Adenosine deaminase (ADA) as an enzyme involved in the purine salv...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Med Biochem
Egile Nagusiak: Ebrahimi-Rad, Mina, Khatami, Shohreh, Ansari, Shahla, Jalylfar, Shohreh, Valadbeigi, Shirin, Saghiri, Reza
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Sciendo 2018
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294093/
https://ncbi.nlm.nih.gov/pubmed/30581348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jomb-2017-0042
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak